Outset Medical, Inc. revenue
Outset Medical, Inc.'s revenue was $119m in fiscal 2025, up 5.1% on the year before. Since fiscal 2018 ($2.0m) it has grown at a compound 79.3% a year. Over the last twelve months it was $118m.
Revenue history
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 15 | 50 | 103 | 115 | 130 | 114 | 119 | 118 |
| Growth on the year before | — | +651.3% | +231.2% | +105.5% | +12.4% | +13.0% | −12.8% | +5.1% | — |
| Gross profit | −6 | −18 | −13 | 8 | 18 | 29 | 39 | 47 | 49 |
| Gross margin | — | — | −26.1% | 7.4% | 15.5% | 22.2% | 33.9% | 39.1% | 41.8% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Products | $84.8M | 71.0% | ▲ 4.7% |
| Consumables Product (part of Products) | $54.1M | 63.8% | ▲ 5.7% |
| Consoles Product (part of Products) | $30.7M | 36.2% | ▲ 3.0% |
| Service and Other Revenue | $34.7M | 29.0% | ▲ 6.0% |
From Outset Medical, Inc.'s 10-K filed February 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Outset Medical, Inc. | $118m | -1.3% | -3.1% |
| Anika Therapeutics, Inc. | $121m | 5.3% | 0.3% |
| Owlet, Inc. | $115m | 28.2% | 29.3% |
| Sanara Medtech Inc. | $110m | 13.0% | 22.6% |
| Xtant Medical Holdings, Inc. | $110m | -14.3% | 17.3% |
| Beta Bionics, Inc. | $127m | 43.7% | — |
Compare with peers
- Anika Therapeutics, Inc. revenue
- Owlet, Inc. revenue
- Sanara Medtech Inc. revenue
- Xtant Medical Holdings, Inc. revenue
- Beta Bionics, Inc. revenue
Head to head: ANIK vs OMOM vs OWLTOM vs SMTIBBNX vs OM
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies